Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Alterola Biotech Inc    ALTA

ALTEROLA BIOTECH INC (ALTA)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 01/02 07:45:33 pm
1.5201 USD   +0.01%
2017 ALTEROLA BIOTEC : ALTA) Files An 8-K Entry into a Material Definitiv..
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
10/16/2017 11/27/2017 11/28/2017 12/19/2017 01/02/2018 Date
3(c) 1.52(c) 0(c) 0(c) 1.5201(c) Last
100 0 1 20 280 Volume
0.00% -49.33% -100.00% Change
More quotes
Company
Alterola Biotech, Inc. is a development stage company.It engages in the development of chewing gums for the delivery of nutraceutical and functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on ALTEROLA BIOTECH INC
2017 ALTEROLA BIOTECH, INC. (OTCMKTS : ALTA) Files An 8-K Entry into a Material Defin..
2017 ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Completion o..
More news
Sector news : Generic Pharmaceuticals
01:38p ABLYNX : Largest Ablynx investor would consider improved Novo Nordisk bid
12:27p BTG : U.S. court invalidates Johnson & Johnson cancer drug patent, hitting UK's ..
01/17 TSX ends up as banks lead rally after rate hike
01/17 ASPEN PHARMACARE : Drugmaker GSK cuts back in Africa to hone emerging markets mo..
01/17 EXCLUSIVE : J&J attracts Chinese interest for diabetes business in potential $3-..
More sector news : Generic Pharmaceuticals
News from SeekingAlpha
2017 Stocks to watch next week
Chart ALTEROLA BIOTECH INC
Duration : Period :
Alterola Biotech Inc Technical Analysis Chart | ALTA | US02152V1035 | 4-Traders
Managers
NameTitle
Michael Frederick Freitag President, CEO, Director, Secretary & Treasurer
Sector and Competitors